NEW YORK (GenomeWeb News) – Noninvasive prenatal test developer Natera has completed a $54.6 million financing round to support its expansion and the rollout of its sequencing-based fetal aneuploidy test called Panorama.

Two new investors, OrbiMed Advisors and Harmony Partners, and other new undisclosed investors joined the company's existing investors, Claremont Creek Ventures, Lightspeed Venture Partners, Founders Fund, and Sequoia Capital.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.